Literature DB >> 4555033

Properties of a dimer of tRNA I Tyr 1 (Escherichia coli).

S K Yang, D G Söll, D M Crothers.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4555033     DOI: 10.1021/bi00762a016

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


× No keyword cloud information.
  7 in total

1.  Alternative designs for construction of the class II transfer RNA tertiary core.

Authors:  T A Nissan; J J Perona
Journal:  RNA       Date:  2000-11       Impact factor: 4.942

2.  Structural probing of a pathogenic tRNA dimer.

Authors:  Marc D Roy; Lisa M Wittenhagen; Shana O Kelley
Journal:  RNA       Date:  2005-03       Impact factor: 4.942

3.  Preparation of active tRNA gene transcripts devoid of 3'-extended products and dimers.

Authors:  N Kholod; K Vassilenko; M Shlyapnikov; V Ksenzenko; L Kisselev
Journal:  Nucleic Acids Res       Date:  1998-05-15       Impact factor: 16.971

4.  Recognition of individual procaryotic and eucaryotic transfer-ribonucleic acids by B subtilis adenine-1-methyltransferase specific for the dihydrouridine loop.

Authors:  H Kersten; R Raettig; J Weissenbach; G Dirheimer
Journal:  Nucleic Acids Res       Date:  1978-08       Impact factor: 16.971

5.  The concept of RNA-assisted protein folding: the role of tRNA.

Authors:  Jan C Biro
Journal:  Theor Biol Med Model       Date:  2012-04-02       Impact factor: 2.432

6.  Molecular crowders and cosolutes promote folding cooperativity of RNA under physiological ionic conditions.

Authors:  Christopher A Strulson; Joshua A Boyer; Elisabeth E Whitman; Philip C Bevilacqua
Journal:  RNA       Date:  2014-01-17       Impact factor: 4.942

7.  Native tertiary structure and nucleoside modifications suppress tRNA's intrinsic ability to activate the innate immune sensor PKR.

Authors:  Subba Rao Nallagatla; Christie N Jones; Saikat Kumar B Ghosh; Suresh D Sharma; Craig E Cameron; Linda L Spremulli; Philip C Bevilacqua
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.